Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1

Blood

Volumn 89, Issue 4, 1997, Pages 1394-1404

  Pulford, Karen ^a   Lamant, Laurence ^b   Morris, Stephan W ^b   Butler, Lisa H ^b   Wood, Katrina M ^b   Stroud, David ^b   Delsol, Georges ^b   Mason, David Y ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY; NUCLEOLIN; NUCLEOPLASMIN;

ARTICLE; CANCER CELL; CHIMERA; ENZYME ANALYSIS; GENE TRANSLOCATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPHOMA; LYMPHOMATOID PAPULOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RELIABILITY; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 0031055562     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1394     Document Type: Article

References (57)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
2. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, Dorfman R: Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphoadenopathy. Blood 68:1042, 1986
3. Agnarsson BA, Kadin ME: Ki-1 positive large cell lymphoma-A morphologic and immunologic study of 19 cases. Am J Surg Pathol 12:264, 1988
4. Kadin ME: Ki-1/CD30+ (anaplastic) large-cell lymphoma: Maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol 12:884, 1994
5. Sandlund JT, Pui C-H, Roberts WM, Santan VM, Morris SW, Berard CW, Hutchinson RE, Ribeiro R, Mahmoud H, Crist WM, Rafferty M, Raimondo SC: Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84:2467, 1994
6. Stein H, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams and Wilkins, 1992, p 675
7. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME: The t(2;5)(p23;q35). A recurring chromosomal abnormality in sinusoidal Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
8. Offit K, Ladanyi M, Gangi M: Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625, 1990
9. NPM/ALK: A distinct clinocopathologic entity. Blood 86:1954, 1995
10. Fischer P, Nacheva E, Mason DY, Sherrington D, Hoyle C, Hayhoe FGJ, Karpas A: Ki-1 (CD30)-positive cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2; 5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood 72:234, 1988
11. Kaneko Y, Frizzera G, Edanura S, Maseki N, Sakurai M, Komada Y, Sakurai M, Tanaka H, Sasaki M, Suchi T, Kikuta A, Wakasa H, Hojo H, Mizutani S: A novel translocation t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
12. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol 71:31, 1989
13. Mason DY, Bastard C, Rimokh R, Dastague N, Huret JL, Kristoffersson U, Magaud JP, Nezelhof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
14. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
15. Greco A, Pierotti MA, Bongarzone I, Pagliardi S, Lanzi C, Della Parta G: TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinoma. Oncogene 7:237, 1992
16. Santoro M, Rosati R, Grieco M, Berlingieri MT, Colucci-D'Amato GL, de Francisci V, Fisco A: The Ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinoma. Oncogene 51:1595, 1990
17. Soman NR, Correa P, Ruiz BA, Wogan GN: The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 88:4892, 1991
18. Sawyers CL, Denny CT: Chronic myelomonocytic leukemia: Tel-a-kinase what ets all about. Cell 77:171, 1994
19. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Lui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leucocyte tyrosine kinase (LTK). Mol Cell Biol (in press)
20. Shiota M, Fujimoto J, Taneka M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mon S: Diagnosis of t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3684, 1994
21. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203, 1990
22. Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453, 1993
23. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC: Large-cell anaplastic lymphoma-specific translocation t(2;5)(p23;q35) in Hodgkin's disease: Indication of a common pathenogenesis. Lancet 345:87, 1995
24. Ebrahim SAD, Ladanyi M, Desai SB, Offit K, Jhanwar SC, Filippa DA, Lieberman PH, Chaganti RSK: Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes Chromosom Cancer 2:27, 1990
25. Ladanyi M, Cavalchire G, Morris SW, Downing J, Filippa DA: Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-asociated t(2;5) translocation in Hodgkin's disease. Am J Pathol 145:1296, 1995
26. Weiss LM, Lopetegui JR, Sun LH, Kamel OW, Chae HK, Glackin C: Absence of the t(2;5) in Hodgkin's disease. Blood 85:2845, 1995
27. Herbst H, Anagnostopoulos J, Heinze B, Durkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86:1694, 1995
28. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M: Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas in other non-Hodgkin's lymphomas of T-cell pheno-type. Blood 86:2321, 1995
29. Lamant L, Meggetto F, Al Saati T, Bruggieres L, Bressac de Paillerets B, Dastague N, Bemheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction and P-80 immunostaining. Blood 87:284, 1996
30. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkaier E, Warnke WA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
31. Dirks WG, Zaborski M, Jager K, Challier C, Shiota M, Quentmeier H, Drexler HG: The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: Absence of t(2;5) in Hodgkin-analogous cell lines. Leukemia 10:142, 1996
32. Pulford K, Micklem K, Thomas J, Jones M, Mason DY: A 72-kD B cell-associated surface glycoprotein expressed at high levels in hairy cell leukaemia and plasma cell neoplasms. Clin Exp Immunol 85:429, 1991
33. Chittal SM, Caveriviere P, Schwarting R, Gerdes J, Al Saati T, Rigal-Huguet F, Stein H, Delsol G: Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel. Am J Surg Pathol 12:9, 1988
34. Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting R, Caveriviere P, Rigal-Huguet F, Mazeroles C, Robert A, Chittal SM: Coexpression of epithelial membrane antigen (EMA), Ki-1 and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59 1988
35. Delsol, G, Blancher A, Al Saati T, Ralfkaier E, Lauritzen A, Brugieres L, Brousset P, Rigal-Huguet F, Mazerolles C, Robert A, Chittal SM: Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas. Br J Cancer 64:321, 1991
36. Al Saati T, Tkaczuk J, Krissansen G, Print C, Pileri S, Ralkkaier E, Grogan TM, Meggetto F, Delsol G: A novel antigen detected by the CBF.78 antibody further distinguishes anaplastic large cell lymphoma from Hodgkin's disease. Blood 86:2741, 1995
37. Erber WN, Pinching AJ, Mason DY: Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1:1042, 1984
38. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immuno-ezymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
39. Battifora H: The multitumour (sausage) tissue block. Novel method for immunohistochemical testing. Lab Invest 55:244, 1986
40. Shi SR, Key ME, Kalra K: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on micro-wave oven heating of tissue sections. J Histochem Cytochem 39:741, 1991
41. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72:284, 1976
42. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriphage T4. Nature 227:680, 1970
43. Yee HT, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, De Wolf-Peeters C, Shiota S, Frizzera G, Inghirami G: Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood 87:1081, 1996
44. Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ, Carroll AJ, Morris ST: The t(3;5)(q25.1:q34) of myelodysplastic syndrome and acute myeloid leukaemia produces a novel fusion gene, NPM-MLF-1. Oncogene 12:265, 1996
45. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ: The t(5;17) variant of acute promyelocytic leukaemia express a nucleo-phosmin-retinoic acid receptor fusion. Blood 87:882, 1996
46. Lopategui JR, Sun LH, Chan JK, Gaffey MJ, Frierson HFJ, Glackin C, Weiss LM: Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. Am J Pathol 146:328, 1995
47. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, le Beau MM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphomas is correlated with clinical features and the presence of a unique chromosomal abnormality. Am J Surg Pathol 14:305, 1990
48. Chan WC, Elmberger G, Lozano MD, Sanger W, Weisenburger DD: Large cell anaplastic lymphoma-specitic translocation in Hodgkin's disease. Lancet 345:918, 1995
49. Downing JR, Ladanyi M, Raffeld M, Weiss LM, Morris SW: Large cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 345:918, 1995
50. Xerri L, Pare P, Hassoun J, Birnbaum D: Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease. J Pathol 178:128, 1996
51. Orscheschek K, Merz H, Hell J, Feller AC: Presence of the t(2;5) in Hodgkin's disease. Blood 86:4383, 1996
52. Ralfkaier E, Stein H, Wantzin GL: Lyinphomatoid papulosis: Characterisation of skin infiltrates by monoclonal antibodies. Am J Clin Pathol 84:587, 1985
53. Davis TH, Morton CC, Miller-cassman R: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115, 1992
54. LeBoit PE: Hodgkin's disease, anaplastic large cell lymphoma, and lymphomatoid papulosis. Am J Clin Pathol 104:3, 1995
55. Cohen PL, Butmarc J, Kadin ME: Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin. Am J Clin Pathol 104:50, 1995
56. McCarty MJ, Vukelja SJ, Sausville EA, Perry JJ, James WD, Jaffe ES, Weiss RB: Lymphomatoid papulosis associated with Ki-1-positive anaplastic large cell lymphoma. Cancer 74:3051, 1994
57. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME: The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437, 1996